Cloud-Based Research Platform
Sign up today and learn more about Benchling Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Benchling Stock
Benchling is a modern software platform purpose-built for life science R&D. Benchling claims its platform can help manage techniques like CRISPR, CAR-T immunotherapy, and genetic engineering with a suite of cloud applications to design DNA and collaborate on experiments, manage research workflows, and make critical R&D decisions. Benchling is used for research on biotherapeutics, biofuels, and biomaterials at life science companies and academic labs.
Benchling was founded in 2012 and is headquartered in San Francisco, California, United States. Notable investors include Thrive Capital, Y Combinator, and SV Angel.
Chief Executive Officer
Chief Financial Officer